1. Home
  2. GOAI vs BDSX Comparison

GOAI vs BDSX Comparison

Compare GOAI & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GOAI

Eva Live Inc. Common Stock

N/A

Current Price

$3.40

Market Cap

150.5M

Sector

Technology

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$14.31

Market Cap

143.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOAI
BDSX
Founded
2015
2005
Country
United States
United States
Employees
3
334
Industry
Computer Software: Programming Data Processing
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.5M
143.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GOAI
BDSX
Price
$3.40
$14.31
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
69.4K
72.3K
Earning Date
04-10-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
N/A
$19.15
P/E Ratio
$18.31
N/A
Revenue Growth
N/A
24.08
52 Week Low
$2.75
$0.26
52 Week High
$6.67
$20.21

Technical Indicators

Market Signals
Indicator
GOAI
BDSX
Relative Strength Index (RSI) 42.52 53.23
Support Level $3.48 $12.77
Resistance Level $4.36 $16.38
Average True Range (ATR) 0.26 1.14
MACD -0.02 0.10
Stochastic Oscillator 31.75 62.18

Price Performance

Historical Comparison
GOAI
BDSX

About GOAI Eva Live Inc. Common Stock

Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: